Read our COVID-19 research and news.

Webinar Technology

Unlocking the power of digitalization for life science and diagnostics services

This webinar is brought to you by the Science/AAAS Custom Publishing Office

Unlocking the power of digitalization for life science and diagnostics services

26 May 2021

9:00 a.m. ET

Register to watch recording


An undeniable trend across the globe today is increased connectivity, particularly through the use of digital technologies such as the electronic devices that allow us to be linked to each other, our workplaces, and a plethora of information sources. The global pandemic has accelerated the acceptance of many of these technologies—think telemedicine, virtual conferences, and remote control of equipment. In life science research, diagnostic, and clinical labs, the uptake of digital connectivity has been proceeding cautiously for a number of years, but has recently also been impacted by pandemic-related pressures. These and other industries have much to gain from connected platforms and digital services, and could take advantage of lessons learned from other pioneering industries. In the same way that the health care sector has seen the benefits of embracing telemedicine, laboratories of all stripes are recognizing the advantages of being able to maximize the use of their equipment, monitor usage, minimize downtime, and use predictive maintenance to reduce equipment failures. Other pluses include remote staff training and customer support and the availability of analytics to track equipment use and productivity.

This webinar will take a hard look at the lab digitalization landscape, highlighting a range of perspectives—from end-users to technology developers.

During the webinar, the speakers will:

  • Define digitalization and show how it can be used to eliminate silos of disconnected data and harness the wealth of data generated by research, diagnostic, and clinical workflows
  • Address common concerns including standardization, compatibility, and privacy
  • Outline pitfalls and benefits—for lab users, managers, and ultimately patients
  • Answer your questions live during the broadcast.

This webinar will last for approximately 60 minutes.

Speaker bios

Frank J. Buescher

SYSMEX Asia Pacific

Mr. Buescher is the president and CEO of Sysmex Asia Pacific and an executive officer at Sysmex Corporation, Japan. Before joining Sysmex he was chief information officer of a large commercial laboratory group in Europe. He has been with Sysmex since 2003, holding positions as senior vice president for Health IT Systems at Sysmex Europe and director for business development at Sysmex Corporation, Japan. He has held his current position since 2008 and since 2021 has also been the executive officer and deputy in charge of digital transformation.

Wael Yared, Ph.D.

Männedorf, Switzerland

Dr. Yared was appointed Chief Technology Officer (CTO), Global Head of Research & Development and a member of the Management Board of Tecan in April 2019. He has over 20 years of research and product development experience, bringing complex product platforms to market across various sectors of human health. He held global R&D leadership responsibilities across automation, liquid handling, microfluidics, imaging and detection, spanning instrument hardware, software and algorithm development, as well as reagents for immunoassay and preclinical molecular imaging. Prior to joining Tecan, he was Chief Technology Officer and Vice President of Corporate Development at US-based BioAnalytix, Inc. From 2010 to 2016, he was Vice President and global R&D Leader of the Life Science & Technology business unit at PerkinElmer Inc. Before that, he was CTO and Vice President R&D at VisEn Medical Inc. from early stage of the Harvard Medical School spin-out to its acquisition by PerkinElmer in 2010. Dr. Yared received his Ph.D. from the Massachusetts Institute of Technology in Cambridge, Massachusetts, for his work on command language algorithms in robotics, and is a named inventor and author on a number of patents and publications.

Sean Sanders, Ph.D.

Washington, DC

Dr. Sanders did his undergraduate training at the University of Cape Town, South Africa, and his Ph.D. at the University of Cambridge, UK, supported by the Wellcome Trust. Following postdoctoral training at the National Institutes of Health and Georgetown University, Dr. Sanders joined TranXenoGen, a startup biotechnology company in Massachusetts working on avian transgenics. Pursuing his parallel passion for writing and editing, Dr. Sanders joined BioTechniques as an editor, before joining Science/AAAS in 2006. Currently, Dr. Sanders is the Director and Senior Editor for Custom Publishing for the journal Science and Program Director for Outreach.

Sponsored by

Get webinar alerts

For more information on upcoming webinars, recorded sessions and more, sign up for webinar alerts.

Sign up here